Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1610.15
-29.15 (-1.78%)
< Home < Back

Sun Pharma gets NCLT’s approval for Scheme of Arrangement

Date: 11-09-2017

Sun Pharmaceutical Industries has received National Company Law Tribunal’s (NCLT) approval for Scheme of Arrangement among Sun Pharma Medisales, Ranbaxy Drugs, Gufic Pharma, Vidyut Investments (collectively known as ‘Transferor Companies’) and Sun Pharmaceutical Industries (the company) and their respective members and creditors (‘Scheme of Arrangement’).

The Company has filed the certified NCLT order with certified Scheme of Arrangement in E-form INC-28 with Registrar of Companies, Gujarat On September 08, 2017 and therefore, the Transferor Companies got merged with the Company with effect from September 08, 2017.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.